Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. September 2023 08:00 ET | Quelle: Nemaura Medical, Inc

Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program

LOUGHBOROUGH, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive...
17. August 2023 08:30 ET | Quelle: Nemaura Medical, Inc

Nemaura Medical Announces SFDA Approval of sugarBEAT®

Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
13. Januar 2022 08:30 ET | Quelle: Nemaura Medical, Inc

Nemaura Medical Launches Metabolic Health Program for Employers and Insurers

Launch into commercial markets offers opportunities for faster and wider adoption of Miboko program Loughborough, England, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)...
15. November 2021 09:30 ET | Quelle: Nemaura Medical, Inc

Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update

Loughborough, England, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
29. September 2021 08:30 ET | Quelle: Nemaura Medical, Inc

Nemaura Medical Launches Beta Version of Its Metabolic Health Program

MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England, Sept. 29, 2021 (GLOBE...